PATENT CLAIM ANALYSIS

Application Number: 16148976
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-06
Patent Classification: ["514", "331000"]

Abstract:
Provided herein are compositions for preventing or treating muscle conditions such as muscle damage, injury, or atrophy. In some embodiments, the compositions comprise a prostaglandin E2 (PGE2) compound and a myotoxin. In some embodiments, the muscle damage, injury, or atrophy is the result of a nerve injury, a surgical procedure, or a traumatic injury. Methods of promoting muscle regeneration and methods of increasing muscle mass are also provided herein.

Claim (Index 2):
The method of  claim 1 , wherein the PGE2 compound is selected from the group consisting of PGE2, a PGE2 derivative, a PGE2 prodrug, a PGE2 receptor agonist, a compound that attenuates PGE2 catabolism, a compound that neutralizes PGE2 inhibition, a derivative thereof, an analog thereof, and a combination thereof.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 97.0
- Lexical Diversity: 1.80435
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15891278', '16022578', '13836794', '13838002', '14783426']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7918309567511987
- 35 USC 102 Novelty (BERT): 0.5999273640348676
- Combined Prediction Score: 0.7726405974795657
- Mean Citation Score: 315.679646
- Max Citation Score: 586.6288
- Similarity Product: 439.97104054718017

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test